EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pharmaco-Omics in Psoriasis: Paving the Way towards Personalized Medicine

Charalabos Antonatos iD, Paschalia Asmenoudi iD, Mariza Panoutsopoulou iD, Yiannis Vasilopoulos

International Journal of Molecular Sciences · 11.04.2023 · 24 (8) · 7090

DOI: 10.3390/ijms24087090 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.04.2023. Verfasst von Charalabos Antonatos und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genetics, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, 26504 Patras, Greece. Hauptthemen laut MEDLINE: Precision Medicine, Psoriasis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research council of the University of Patras.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of high-throughput approaches has had a profound impact on personalized medicine, evolving the identification of inheritable variation to trajectory analyses of transient states and paving the way for the unveiling of response biomarkers. The utilization of the multi-layered pharmaco-omics data, including genomics, transcriptomics, proteomics, and relevant biological information, has facilitated the identification of key molecular biomarkers that can predict the response to therapy, thereby optimizing treatment regiments and providing the framework for a tailored treatment plan. Despite the availability of multiple therapeutic options for chronic diseases, the highly heterogeneous clinical response hinders the alleviation of disease signals and exacerbates the annual burden and cost of hospitalization and drug regimens. This review aimed to examine the current state of the pharmaco-omic approaches performed in psoriasis, a common inflammatory disease of the skin. We sought to identify central studies that investigate the inter-individual variability and explore the underlying molecular mechanisms of drug response progression via biological profiling in psoriatic patients administered with the extended therapeutic armamentarium of psoriasis, incorporating conventional therapies, small molecules, as well as biological drugs that inhibit central pathogenic cytokines involved in the disease pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicinePsoriasisHumansGenomicsProteomicsBiomarkers

Stichwörter der Autor:innen

pharmaco-omicspharmacogenomicspharmacotranscriptomicsprecision medicinepsoriasis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Laboratory of Genetics, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, 26504 Patras, Greece.

ORCID-Profile: Charalabos Antonatos, Paschalia Asmenoudi, Mariza Panoutsopoulou

Förderung

  • Research council of the University of Patras

Zitieren

APA

Antonatos, C., Asmenoudi, P., Panoutsopoulou, M., & Vasilopoulos, Y. (2023). Pharmaco-Omics in Psoriasis: Paving the Way towards Personalized Medicine. International Journal of Molecular Sciences, 24(8), 7090. https://doi.org/10.3390/ijms24087090

Vancouver

Antonatos C, Asmenoudi P, Panoutsopoulou M, Vasilopoulos Y. Pharmaco-Omics in Psoriasis: Paving the Way towards Personalized Medicine. International Journal of Molecular Sciences. 2023;24(8):7090. doi:10.3390/ijms24087090

BibTeX
@article{Antonatos2023,
  author = {Antonatos, Charalabos and Asmenoudi, Paschalia and Panoutsopoulou, Mariza and Vasilopoulos, Yiannis},
  title = {Pharmaco-Omics in Psoriasis: Paving the Way towards Personalized Medicine},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {8},
  pages = {7090},
  doi = {10.3390/ijms24087090}
}
Kostenlos starten →